Bioequivalence and Bioavailability Forum 00:53 CET

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log in |  Register |  Search

Usage of function CVfromCI (package PowerTOST) [R for BE/BA]

posted by Elena777 - Belarus, 2018-01-20 11:13  - Posting: # 18229
Views: 1,918

(edited by Elena777 on 2018-01-21 08:46)

Dear participants of forum, I am relatively new to R and RStudio. And I really need your advise to clear some questions up which are important for my self-education and professional skills.

1. A BE study of Sotalol HCl 160 mg tablets (Mylan) and Betapace 160 mg tablets (Berlex Laboratories) with standard 2x2 cross-over design was described in one of the applications on FDA (application number 75-725). They planned to enroll 24 subjects. But in fact that study was conducted with 23 subjects. I would like to calculate CV from CI using data of that study. What data should I write for arguments "n" and "design"? If I input such data:

CVfromCI(pe = 0.99, lower = 0.87, upper = 1.13, n = 23, design = "2x2", alpha = 0.05, robust=FALSE)

RStudio gives me a result but with the following note:

CVfromCI(pe = 0.99, lower = 0.87, upper = 1.13, n = 23, design = "2x2", alpha = 0.05, robust=FALSE)
Unbalanced 2x2 design. n(i)= 12/11 assumed.
[1] 0.2617363


Can I use this result for futher calculations of CVpooled by means of using PowerTOST or should I correct my data?

2. While calculating CV from CI with data from another study I`ve got the following result:

CVfromCI(pe = 0.96, lower = 0.9075, upper = 1.0089, n = 24, design = "2x2", alpha = 0.05, robust=FALSE)
[1] 0.1071475
Warning message:
sigma based on pe & lower CL more than 10% different than sigma based on pe & upper CL. Check input.


My input is correct because numbers are taken from that application not from my head. Should I pay attention to this warning message and can I use this result for futher calculations of CVpooled by PowerTOST?

3. While calculating CV from CI is it prefered to use CI for log-transformed parameters (for example LCmax) or for non-transformed parameters(Cmax)?


Big thanks in advance. :-)

Complete thread:

Activity
 Mix view
Bioequivalence and Bioavailability Forum |  Admin contact
19,154 posts in 4,080 threads, 1,308 registered users;
online 17 (0 registered, 17 guests [including 9 identified bots]).

One can show the following: given any rule, however “fundamental”
or “necessary” for science, there are always circumstances
when it is advisable not only to ignore the rule,
but to adopt its opposite.    Paul Feyerabend

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5 RSS Feed